Peptide codes for organ-selective mRNA delivery
- PMID: 40890497
- DOI: 10.1038/s41563-025-02331-6
Peptide codes for organ-selective mRNA delivery
Abstract
Organ-selective delivery of messenger RNA (mRNA) is critical for fulfilling the therapeutic potential of mRNA-based gene and protein replacement technologies. Despite clinical advances in the hepatic delivery of mRNA using lipid nanoparticles (LNPs), current strategies for extrahepatic-organ-selective mRNA delivery still have limitations. Here we report a peptide-encoded organ-selective targeting (POST) method for the delivery of mRNA to extrahepatic organs after systemic administration, which is based on the modular tuning of LNPs through surface engineering with specific amino acid sequences (POST codes). Molecular dynamics simulations and in vitro and in vivo testing show that the organ-selective targeting of POST results from the specific protein corona of the peptide-decorated LNPs, which is established from the mechanical optimization of the binding affinities between peptides with a particular sequence and plasma proteins. This approach can be used for the organ-selective delivery of different ribonucleic acids and multiple gene editing machinery. Overall, the POST platform creates a modular repertoire for LNP surface engineering for directing organ tropism, broadening the scope and versatility of organ-selective delivery.
© 2025. The Author(s), under exclusive licence to Springer Nature Limited.
Conflict of interest statement
Competing interests: Y.S. and T.C. have filed a patent in the China National Intellectual Property Administration (patent no. 202310977908.7) based on the POST platform developed in this study. The remaining authors declare no competing interests.
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Nucleic Acid Nanocapsules as a New Platform to Deliver Therapeutic Nucleic Acids for Gene Regulation.Acc Chem Res. 2025 Jul 1;58(13):1951-1962. doi: 10.1021/acs.accounts.5c00126. Epub 2025 Jun 9. Acc Chem Res. 2025. PMID: 40491030
-
Endogenous Corticosteroid Derived Lipid Nanoparticles (Cortico LNPs) Enable Selective mRNA Delivery to the Spleen.Small. 2025 Jul 25:e03034. doi: 10.1002/smll.202503034. Online ahead of print. Small. 2025. PMID: 40711370
-
Recent Advances in mRNA-LNP Delivery Systems for Extrahepatic Organs: A Review.Mol Pharm. 2025 Aug 4;22(8):4474-4493. doi: 10.1021/acs.molpharmaceut.5c00385. Epub 2025 Jul 11. Mol Pharm. 2025. PMID: 40641444 Review.
-
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260. Health Technol Assess. 2001. PMID: 11701099
Cited by
-
Switching a chiral antiferromagnet.Nat Mater. 2025 Sep;24(9):1322-1323. doi: 10.1038/s41563-025-02266-y. Nat Mater. 2025. PMID: 40523924 No abstract available.
-
Reconfigurable magnetic order in 2D materials.Nat Mater. 2025 Sep;24(9):1324-1325. doi: 10.1038/s41563-025-02304-9. Nat Mater. 2025. PMID: 40759721 No abstract available.
-
A tug-of-war recipe for nanoscale swirls.Nat Mater. 2025 Sep;24(9):1326-1327. doi: 10.1038/s41563-025-02288-6. Nat Mater. 2025. PMID: 40670707 No abstract available.
References
-
- Barbier, A. J., Jiang, A. Y., Zhang, P., Wooster, R. & Anderson, D. G. The clinical progress of mRNA vaccines and immunotherapies. Nat. Biotechnol. 40, 840–854 (2022). - PubMed
-
- Miao, L. et al. Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation. Nat. Biotechnol. 37, 1174–1185 (2019). - PubMed
-
- Liu, C. et al. mRNA-based cancer therapeutics. Nat. Rev. Cancer 23, 526–543 (2023). - PubMed
-
- Rohner, E., Yang, R., Foo, K. S., Goedel, A. & Chien, K. R. Unlocking the promise of mRNA therapeutics. Nat. Biotechnol. 40, 1586–1600 (2022). - PubMed
Grants and funding
- U21A20203/National Natural Science Foundation of China (National Science Foundation of China)
- 12102229/National Natural Science Foundation of China (National Science Foundation of China)
- 22175188/National Natural Science Foundation of China (National Science Foundation of China)
- 32400944/National Natural Science Foundation of China (National Science Foundation of China)
- Z220022/Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation)
LinkOut - more resources
Full Text Sources